Technical Analysis – Moderna rebound runs out of steam as 50-MA caps gains
The RSI has just slipped below the 50-neutral level, while the fast (%K) stochastic is about to enter the oversold region. However, the MACD has remained close to zero and is holding above its red signal line for now, casting doubt on the strength of the short-term bearish bias.
There is immediate support from the 20-day SMA around 107.75. If the stock fails to bounce off the 20-day SMA, the next target for the bears could be the 33-month low of 94.70. Breaching this as well would reinforce the long-term downtrend and open the way for the 80 level, which acted as resistance back in October 2020.
However, if the bearish momentum fades and the price reverses higher, there’s likely to be another major test at the 50-day SMA, currently at 114.35. A break higher would bring into focus the 23.6% Fibonacci retracement of the December 2022-August 2023 downtrend at 123.55. But for a more sustainable uptrend, the bulls would at least have to climb all the way to the 38.2% Fibonacci of 141.40, which lies slightly below the 200-day SMA.
In brief, the selling pressure is likely to accelerate if the price drops below the 20-day SMA. But should it hold, there are a number of obstacles standing in the way of a more meaningful recovery in the stock.Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
